logo de ProBioQual
Association for the Promotion of Quality Control in Medical Biology
COFRAC logo
Sub-family: General & specialised biochemistry Image Biochimie
2027 EQA PROGRAMS
EQA 2027 - Tumour markers and general hormone testing (CIMD)
Expert Biologists - Program Coordinators:
Marie LOPEZ and Laetitia SELMAN
EQA performed since 1977
Number of analytical sites registered in 2026: 697

1 – Program overview

This external quality assessment program evaluates the accuracy of tumour marker and general hormone assays, with an interlaboratory comparison by peer group.

Statistical reports are sent with supporting comments from the expert clinical biologists / program coordinators.

Participating labs can choose to be assessed for all the analytes of this program, or simply a subset of analytes of interest.

panneau attention Sample volume: if necessary, order an additional kit.

2 – Assessment frequency

Number of surveys per year: 6
Number of control samples per survey: 1 or 2
Number of samples per year: 9

3 – List of analytes assessed 

  • AFP
  • Beta-2 microglobulin
  • C-peptide
  • CA 125
  • CA 15-3
  • CA 19-9
  • CEA
  • Cortisol
  • DHT (dihydrotestosterone)
  • EPO
  • Estradiol
  • Ferritin
  • Folate
  • Free PSA
  • Free T3
  • Free T4
  • New - Free/total PSA ratio
  • FSH
  • GH
  • New - HE4*
  • Insulin
  • LH
  • Parathyroid hormone
  • Progesterone
  • Prolactin
  • S100B protein
  • Testosterone
  • Total hCG
  • Total IgE (allergy)
  • Total PSA
  • TSH
  • Vitamin B12
*analyte not covered by accreditation

4 – Description of the control samples

Lyophilised human control serum (samples to be resuspended in 3 mL of distilled water).

Contact us
ProBioQual
7, Rue Antoine Lumière - 69008 LYON - FRANCE
Tel: +33 (0)4 72 65 34 90
E-mail: secretariat@probioqual.com
| Legal notices and privacy policy | General terms of sale | Last updated: 13 October 2026 Copyright © 2011-2026 ProBioQual All rights reserved